These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 30421278)

  • 1. Lessons from one year experience of pooled procurement of pharmaceuticals: exploration of indicators and assessing pharmacies` performance.
    Bastani P; Imanieh MH; Dorosti H; Abbasi R; Dashti SA; Keshavarz K
    Daru; 2020 Jun; 28(1):13-23. PubMed ID: 30421278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specialty pharmacies and other restricted drug distribution systems: financial and safety considerations for patients and health-system pharmacists.
    Kirschenbaum BE
    Am J Health Syst Pharm; 2009 Dec; 66(24 Suppl 7):S13-20. PubMed ID: 19966075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medicine procurement in hospital pharmacies of Nepal: A qualitative study based on the Basel Statements.
    Shrestha M; Moles R; Ranjit E; Chaar B
    PLoS One; 2018; 13(2):e0191778. PubMed ID: 29401474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One-year assessment of joint procurement of pharmaceuticals in the public health sector in Jordan.
    Al-Abbadi I; Qawwas A; Jaafreh M; Abosamen T; Saket M
    Clin Ther; 2009 Jun; 31(6):1335-44. PubMed ID: 19695398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Qualitative analysis of national documents on health care services and pharmaceuticals` purchasing challenges: evidence from Iran.
    Bastani P; Samadbeik M; Dinarvand R; Kashefian-Naeeini S; Vatankhah S
    BMC Health Serv Res; 2018 Jun; 18(1):410. PubMed ID: 29871679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of the Group Purchasing Structure in the Field of Pharmaceuticals and Medical Devices: The Case of Public Pharmacies.
    Rahim M; Esmaeili S; Peikanpour M
    Iran J Pharm Res; 2022 Dec; 21(1):e130522. PubMed ID: 36915403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prime vendor purchasing of pharmaceuticals in the Veterans Affairs health care system.
    Patterson AA; Pierce RA; Powell AP
    Am J Health Syst Pharm; 1995 Sep; 52(17):1886-9. PubMed ID: 8528850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liberalization and integration of drug distribution in the EU 28 and Norway.
    Písek J; Pícha K
    Ceska Slov Farm; 2018; 67(1):14-24. PubMed ID: 30157663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergency drug kits at the Danish hospital pharmacies: varying management and challenges.
    Christensen M; Knudsen SA; Plet H; Lyngsø SB; Olesen AE
    Eur J Hosp Pharm; 2020 Jul; 27(4):232-236. PubMed ID: 32587083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of drug-procurement alternatives.
    May BE; Herrick JD
    Am J Hosp Pharm; 1984 Jul; 41(7):1373-8. PubMed ID: 6465153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Managing prices for hospital pharmaceuticals: a successful strategy for New Zealand?
    Tordoff JM; Norris PT; Reith DM
    Value Health; 2005; 8(3):201-8. PubMed ID: 15877592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Service quality in outpatient teaching hospital pharmacies based on the SERVQUAL model: An assessment in the south of Iran.
    Kashfi SM; Karimian E; Ravangard R; Mehralian G; Bastani P
    Int J Pharm Pract; 2022 May; 30(2):153-159. PubMed ID: 35201321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost containment through pharmaceutical procurement: a Caribbean case study.
    Huff-Rousselle M; Burnett F
    Int J Health Plann Manage; 1996; 11(2):135-57. PubMed ID: 10172681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An analysis of 1986 drug procurement practices in hospitals within the United States.
    Smolarek RT; Powell MF; Solomon DK; Boike SC
    Hosp Pharm; 1989 Sep; 24(9):721-4, 727-31, 734. PubMed ID: 10318327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility of prime vendor purchasing for a state university hospital.
    Olson SM; Hammel RW; Liegel AR
    Am J Hosp Pharm; 1985 Mar; 42(3):566-70. PubMed ID: 3985019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compounding practices in Iran.
    Goodarzi N; Niknam S; Akbarzadeh T; Gholami K
    Int J Pharm Compd; 2014; 18(2):112-6. PubMed ID: 24881113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The vacated space of volume/price of the drugs centralized procurement with quantity in secondary and above public hospitals of China.
    Wang J; Zhang S; Wang C; Li J; Wang R; Zhu L
    BMC Health Serv Res; 2024 Jun; 24(1):771. PubMed ID: 38951849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Providing a framework for assessment of the access to medicine.
    Afzali M; Khorasani E; Alvandi M; Sabbagh-Bani-Azad M; Sharif Z; Saiyarsarai P; Nikfar S
    Daru; 2019 Jun; 27(1):243-254. PubMed ID: 31055777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of pricing policy on the prices and supply of low-cost medicines in Shandong, China: evidence from an interrupted time series analysis.
    Rong X; Yin J; Duan S; Sun Q; Babar ZU
    BMC Public Health; 2020 Apr; 20(1):588. PubMed ID: 32349722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Applying management science in developing countries: ABC analysis to plan public drug procurement.
    Quick JD
    Socioecon Plann Sci; 1982; 16(1):39-50. PubMed ID: 10317211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.